Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx O Supply Disruption — Lupin Pharmaceuticals Inc. (M
Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx O Supply Disruption — Lupin Pharmaceuticals Inc. (M is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx O; Manufacturer: Lupin
| Drug name | Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx O |
|---|---|
| Manufacturer | Lupin Pharmaceuticals Inc. |
| Recall/Disruption reason | Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0855-2020 |
| Initiation date | 20200212 |
| Quantity affected | 6,294 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →